YOUR SEARCH FOR Text 61 RESULTS
51 of Total
Incyte to Present at Upcoming Investor Conference | Incyte
… 18, 2025-- Incyte (Nasdaq:INCY) announced today that it will present at the 44 th Annual …
52 of Total
Incyte to Present at Upcoming Investor Conferences | Incyte
… 17, 2026-- Incyte (Nasdaq:INCY) announced today that it will present at the following …
53 of Total
Incyte Announces Change to its Board of Directors | Incyte
… WIRE)--Dec. 12, 2025-- Incyte (Nasdaq:INCY) today announced the resignation of Hervé …
54 of Total
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results | Incyte
… 27, 2026-- Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter …
55 of Total
An Inclusive Environment | Incyte.com
Incyte: Our Commitment to Inclusion Incyte is a global biopharmaceutical company that seeks to develop and bring to market treatments for people
56 of Total
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapse
… WIRE)--Dec. 17, 2025-- Incyte (Nasdaq:INCY) today announced that the European Commission …
57 of Total
Prospective Suppliers | Incyte.com
… If you would like to contact us and share information about your business and core …
58 of Total
Drug Development & Scientific Innovation in Hematology, Oncology and Inflammation and Autoimmunity,
… Approach Collaboration around this shared purpose starts from the ground up. Our …
59 of Total
Supplement to Consumer Health Data Privacy Policy for Nevada Consumers | Incyte.com
… of Processing. We Collect, use, Process, and Share Consumer Health Data for the purposes and …
60 of Total
Resources | Incyte
… to treat your data with respect and will not share your information with any third party. You …